Centromere protein F and survivin are associated with high risk and a poor prognosis in colorectal gastrointestinal stromal tumours

Journal of Clinical Pathology

Volumn 64, Issue 9, 2011, Pages 751-755

  Chen, Wen Bin ^a   Cheng, Xiao Bin ^a   Ding, Wei ^a   Wang, Yang Jing ^a   Chen, Dong ^a   Wang, Jin Hai ^a   Fei, Ru Shan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CENTROMERE PROTEIN F; NUCLEAR PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CENTROMERE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; AGED; CHINA; CHROMOSOMAL PROTEINS, NON-HISTONE; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 80051885418     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2011.089631     Document Type: Article

References (25)

1. Kitamura Y. Gastrointestinal stromal tumors: Past, present, and future. J Gastroenterol 2008;43:499-508.
2. Connolly E.M., Gaffney E., Reynolds J.V. Gastrointestinal stromal tumours. Br J Surg 2003;90:1178-1186 (Pubitemid 37330419)
3. Perez D., Herrmann T., Jungbluth A.A., et al. Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence. Int J Cancer 2008;123:1551-1555
4. Nasu K., Ueda T., Kai S., et al. Gastrointestinal stromal tumor arising in the rectovaginal septum. Int J Gynecol Cancer 2004;14:373-377 (Pubitemid 38533913)
5. Logrono R., Bhanot P., Chaya C., et al. Imaging, morphologic, and immunohistochemical correlation in gastrointestinal stromal tumors. Cancer 2006;108:257-266 (Pubitemid 44835773)
6. Varis A., Salmela A.L., Kallio M.J. Cenp-F (mitosin) is more than a mitotic marker. Chromosoma 2006;115:288-295 (Pubitemid 43923355)
7. Brenner S., Pepper D., Berns M.W., et al. Kinetochore structure, duplication, and distribution in mammalian cells: Analysis by human autoantibodies from scleroderma patients. J Cell Biol 1981;91:95-102. (Pubitemid 12252769)
8. Yang Z.Y., Guo J., Li N., et al. Mitosin/CENP-F is a conserved kinetochore protein subjected to cytoplasmic dynein-mediated poleward transport. Cell Res 2003;13:275-283 (Pubitemid 43225256)
9. Amon A. The spindle checkpoint. Curr Opin Genet Dev 1999;9:69-75. (Pubitemid 29080389)
10. Rieder C.L., Salmon E.D. The vertebrate cell kinetochore and its roles during mitosis. Trends Cell Biol 1998;8:310-318 (Pubitemid 28362588)
11. De la Guardia C., Casiano C.A., Trinidad-Pinedo J., et al. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 2001;23:104-112 (Pubitemid 32063187)
12. O'Brien S.L., Fagan A., Fox E.J., et al. CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer 2007;120:1434-1443 (Pubitemid 46355377)
13. Bencimon C., Salles G., Moreira A., et al. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma. Ann N Y Acad Sci 2005;1050:319-326 (Pubitemid 41129450)
14. Sah N.K., Khan Z., Khan G.J., et al. Structural, functional and therapeutic biology of survivin. Cancer Lett 2006;244:164-171 (Pubitemid 44485888)
15. Reed J.C., Bischoff J.R. BIRinging chromosomes through cell division - and survivin'the experience. Cell 2000;102:545-548
16. Tran J., Master Z., Yu J.L., et al. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci U S A 2002;99:4349-4354 (Pubitemid 34285988)
17. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921 (Pubitemid 27353455)
18. Zhen H.N., Zhang X., Hu P.Z., et al. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Cancer 2005;104:2775-2783 (Pubitemid 41798288)
19. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581-8589 (Pubitemid 38019195)
20. Altieri D.C. Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm. J Cell Biochem 2004;92:656-663 (Pubitemid 44264257)
21. Kawasaki H., Altieri D.C., Lu C.D., et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998;58:5071-5074 (Pubitemid 28521163)
22. Kawasaki H., Toyoda M., Shinohara H., et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumourigenesis. Cancer 2001;91:2026-2032 (Pubitemid 32476366)
23. Fletcher C.D., Berman J.J., Corless C., et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-465 (Pubitemid 34747864)
24. Esguerra R.L., Jia L., Kaneko T., et al. Immunohistochemical analysis of centromere protein F expression in buccal and gingival squamous cell carcinoma. Pathol Int 2004;54:82-89 (Pubitemid 38979629)
25. Koon N., Schneider-Stock R., Sarlomo-Rikala M., et al. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 2004;53:235-240 (Pubitemid 38125511)